Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer

You may be eligible if

• Patients that have received Abraxane chemotherapy greater than three months from the time of chart review.
• Patients that have received taxane chemotherapy greater than three months from the time of chart review.